Demo Data from EDBT 2026 / reviewers in the wild / expert
Gareth Peat
dblp:236/0423
· DBLP profile ↗
1ranked-venue papers
1as first author
0since 2021 · last 2020
—ORCID · unresolved
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 5 heaviest of 5, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › statistical genetics › post-GWAS analysis
causal gene identification |
0.4 | 1 | 2020 | The open targets post-GWAS analysis pipeline · Bioinform. 2020 |
Bioinformatics and computational biology
genomics |
0.4 | 1 | 2020 | The open targets post-GWAS analysis pipeline · Bioinform. 2020 |
Bioinformatics and computational biology › statistical genetics
post-GWAS analysis |
0.4 | 1 | 2020 | The open targets post-GWAS analysis pipeline · Bioinform. 2020 |
Bioinformatics and computational biology
drug discovery |
0.1 | 1 | 2020 | The open targets post-GWAS analysis pipeline · Bioinform. 2020 |
Bioinformatics and computational biology › drug discovery
target identification |
0.1 | 1 | 2020 | The open targets post-GWAS analysis pipeline · Bioinform. 2020 |
Methods — techniques the papers use, named apart from their topics
eQTL analysis · 0.4data integration · 0.4chromatin interaction analysis · 0.4
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2020 | The open targets post-GWAS analysis pipelineabstractMOTIVATION: Genome-wide association studies (GWAS) are a powerful method to detect even weak associations between variants and phenotypes; however, many of the identified associated variants are in non-coding regions, and presumably influence gene expression regulation. Identifying potential drug targets, i.e. causal protein-coding genes, therefore, requires crossing the genetics results with functional data. RESULTS: We present a novel data integration pipeline that analyses GWAS results in the light of experimental epigenetic and cis-regulatory datasets, such as ChIP-Seq, Promoter-Capture Hi-C or eQTL, and presents them in a single report, which can be used for inferring likely causal genes. This pipeline was then fed into an interactive data resource. AVAILABILITY AND IMPLEMENTATION: The analysis code is available at www.github.com/Ensembl/postgap and the interactive data browser at postgwas.opentargets.io. Gareth Peat, Michael Nuhn, José Carlos Marugán, William Newell, Ian Dunham, Daniel R. Zerbino |
Bioinform. | 1 |